Schayowitz Adam
SEC insider (Form 3/4/5 filer). CIK 0002127119. Insider at Faeth Therapeutics, Inc. (FTH) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Oct 23, 2026. Located in AUSTIN, TX.
Companies Schayowitz Adam has filed insider reports for
- Faeth Therapeutics, Inc. (FTH)
- Zymeworks Inc. (ZYME): Officer, EVP, Head of R&D
Schayowitz Adam
CIK: 0002127119
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Oct 23, 2026FTH
Faeth Therapeutics, Inc.
AwardDirectStock Option (right to buy)
25K shares- - Oct 9, 2026ZYME
Zymeworks Inc.
ExerciseDirect37K shares- - Oct 9, 2026ZYME
Zymeworks Inc.
SaleDirect13.8K shares at avg. $25.85$358K - Apr 9, 2026ZYME
Zymeworks Inc.
AwardDirectStock Option (Right to Buy)
70K shares- - Apr 9, 2026ZYME
Zymeworks Inc.
AwardDirectRestricted Stock Unit
47K shares- - Apr 9, 2026ZYME
Zymeworks Inc.
AwardDirectPerformance Stock Unit
76K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 23, 2026 |  FTH Faeth Therapeutics, Inc. | Award Stock Option (right to buy) | 25,000 | - | - | Direct |
| Oct 9, 2026 |  ZYME Zymeworks Inc. | Exercise | 37,037 | - | $0 | Direct |
| Oct 9, 2026 | ZYME Zymeworks Inc. | Sale | 13,832 | $25.85 | $357,557 | Direct |
| Apr 9, 2026 | ZYME Zymeworks Inc. | Award Stock Option (Right to Buy) | 70,000 | - | - | Direct |
| Apr 9, 2026 | ZYME Zymeworks Inc. | Award Restricted Stock Unit | 47,000 | - | - | Direct |
| Apr 9, 2026 | ZYME Zymeworks Inc. | Award Performance Stock Unit | 76,000 | - | - | Direct |
1-6 of 6 transactions